Yueyong Liu
Overview
Explore the profile of Yueyong Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
610
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yue Y, Leung S, Liu Y, Huang Y, Grundt K, Ostvold A, et al.
Oncotarget
. 2016 Aug;
7(38):61874-61889.
PMID: 27542204
NUCKS1 is a 27 kD vertebrate-specific protein, with a role in the DNA damage response. Here, we show that after 4 Gy total-body X-irradiation, Trp53+/- Nucks1+/- mice more rapidly developed...
2.
Snijders A, Liu Y, Su L, Huang Y, Mao J
Oncotarget
. 2015 Nov;
6(42):44794-805.
PMID: 26575021
The tumor suppressor gene FBXW7 is deleted and mutated in many different types of human cancers. FBXW7 primarily exerts its tumor suppressor activity by ubiquitinating different oncoproteins including mTOR. Here...
3.
Georgescu W, Osseiran A, Rojec M, Liu Y, Bombrun M, Tang J, et al.
PLoS One
. 2015 Jun;
10(6):e0129438.
PMID: 26107175
Traditionally, the kinetics of DNA repair have been estimated using immunocytochemistry by labeling proteins involved in the DNA damage response (DDR) with fluorescent markers in a fixed cell assay. However,...
4.
Dai X, Liu P, Lau A, Liu Y, Inuzuka H
Cancer Med
. 2014 Aug;
3(5):1211-24.
PMID: 25116380
Induced pluripotent stem (iPS) cells can be generated from somatic cells by coexpression of four transcription factors: Sox2, Oct4, Klf4, and c-Myc. However, the low efficiency in generating iPS cells...
5.
Wang L, Ye X, Liu Y, Wei W, Wang Z
Oncotarget
. 2014 Jun;
5(8):2000-15.
PMID: 24899581
FBW7 (F-box and WD repeat domain-containing 7) or Fbxw7 is a tumor suppressor, which promotes the ubiquitination and subsequent degradation of numerous oncoproteins including Mcl-1, Cyclin E, Notch, c- Jun,...
6.
Wang Z, Liu Y, Zhang P, Zhang W, Wang W, Curr K, et al.
Oncotarget
. 2013 Dec;
4(12):2476-86.
PMID: 24344117
Amplification of chromosome 20q is frequently found in various types of human cancers, including breast cancer. The list of candidate oncogenes in 20q has expanded over the past decade. Here,...
7.
Wang Y, Wen M, Kwon Y, Xu Y, Liu Y, Zhang P, et al.
Cancer Res
. 2013 Dec;
74(2):520-31.
PMID: 24305877
The ubiquitin ligase CUL4A has been implicated in tumorigenesis, but its contributions to progression and metastasis have not been evaluated. Here, we show that CUL4A is elevated in breast cancer...
8.
Wang Y, Liu Y, Lu J, Zhang P, Wang Y, Xu Y, et al.
Biochem Biophys Res Commun
. 2013 Apr;
434(2):352-6.
PMID: 23558291
Increased cell migration and invasion lead to cancer metastasis and are crucial to cancer prognosis. In this study, we explore whether FBXW7 plays any role in metastatic process. We show...
9.
Liu Y, Huang Y, Wang Z, Huang Y, Li X, Louie A, et al.
Aging (Albany NY)
. 2013 Mar;
5(2):111-9.
PMID: 23454868
FBXW7 acts as a tumor suppressor in numerous types of human cancers through ubiquitination of different oncoproteins including mTOR. However, how the mutation/loss of Fbxw7 results in tumor development remains...
10.
Liu Y, Ren S, Castellanos-Martin A, Perez-Losada J, Kwon Y, Huang Y, et al.
PLoS One
. 2012 Nov;
7(11):e49453.
PMID: 23166673
FBXW7 acts as a tumor suppressor through ubiquitination and degradation of multiple oncoproteins. Loss of FBXW7 expression, which could be partially attributed by the genomic deletion or mutation of FBXW7...